Denali Therapeutics Inc (DNLI)
Cost of Revenue
$5.80M
TTM · Period ending: · USD
DNLI Cost of Revenue
Latest reported$5.80Mperiod ending
Latest reported$5.80Mperiod ending
DNLI TTM Cost of Revenue ($0.00 → $5.80M)
TTM cost of revenue
High-resolution chart · PNG
DNLI cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 5,804,000 | |
| 5,711,000 | |
| 2,866,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |